Kavar Capital Partners Group’s Eterna Therapeutics ERNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1	Closed	-$4K	–	193
2018 Q2	$4K	Hold	1	–	–	﹤0.01%	381
2018 Q1	$6K	Buy	+1	New	+$6K	﹤0.01%	357